• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮的临床表现:一项开罗-格拉斯哥合作研究。

The clinical manifestations of systemic lupus erythematosus: a Cairo-Glasgow co-operative study.

作者信息

Grennan D M, Ghobarey A F, Hadidi T, El-Badawey S, Hamid H A, Dick W C, Buchanan W W

出版信息

Scott Med J. 1977 Apr;22(2):139-45. doi: 10.1177/003693307702200210.

DOI:10.1177/003693307702200210
PMID:140459
Abstract

The clinical features of 78 patients with SLE seen in Cairo and Glasgow are reviewed. Raynaud's phenomenon was recorded more frequently here than in previous series. The value of serial measurements of anti-DNA antibodies, C3 and C4 in the management of SLE is discussed. Although antibodies to native DNA paralleled the disease course in only a minority of SLE patients anti-DNA antibodies were present during all major SLE exacerbations and could be diagnostically useful. Serious systemic infections complicating the management of SLE patients could occur and their diagnosis is discussed.

摘要

对在开罗和格拉斯哥就诊的78例系统性红斑狼疮(SLE)患者的临床特征进行了回顾。与之前的系列研究相比,这里记录到的雷诺现象更为常见。讨论了抗DNA抗体、C3和C4的系列测量在SLE治疗中的价值。虽然仅少数SLE患者中天然DNA抗体与疾病病程平行,但在所有主要的SLE病情加重期间均存在抗DNA抗体,且具有诊断意义。SLE患者治疗过程中可能会出现严重的全身感染,并对其诊断进行了讨论。

相似文献

1
The clinical manifestations of systemic lupus erythematosus: a Cairo-Glasgow co-operative study.系统性红斑狼疮的临床表现:一项开罗-格拉斯哥合作研究。
Scott Med J. 1977 Apr;22(2):139-45. doi: 10.1177/003693307702200210.
2
The significance of serial measurement of serum anti-native DNA antibodies and complement C3 and C4 components in the management of patients with systemic lupus erythematosus.血清抗天然DNA抗体及补体C3和C4成分的系列测定在系统性红斑狼疮患者管理中的意义
Aust N Z J Med. 1977 Dec;7(6):625-9. doi: 10.1111/j.1445-5994.1977.tb02319.x.
3
Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.系统性红斑狼疮中抗核抗体、抗DNA抗体水平与补体之间的相关性
Acta Med Hung. 1988;45(2):145-59.
4
Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.系统性红斑狼疮中抗DNA抗体、补体消耗与循环免疫复合物之间的关系。
Clin Exp Immunol. 1977 May;28(2):226-32.
5
[The autoantibody profile and disease activity in patients with systemic lupus erythematosus].[系统性红斑狼疮患者的自身抗体谱与疾病活动度]
Vnitr Lek. 1997 Oct;43(10):639-44.
6
Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.青少年和成人系统性红斑狼疮发病的免疫学及临床差异
Lupus. 1999;8(4):287-92. doi: 10.1191/096120399678847786.
7
The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.狼疮性肾炎患者血清补体C3和C4成分及DNA结合能力系列测定的意义
Clin Nephrol. 1979 Oct;12(4):148-55.
8
Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.抗DNA抗体及特定实验室检查在系统性红斑狼疮中的预测价值
J Rheumatol. 1980 Nov-Dec;7(6):843-9.
9
Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.系统性红斑狼疮患者外周动脉疾病:一项前瞻性对照研究。
Int J Rheum Dis. 2013 Jun;16(3):319-24. doi: 10.1111/1756-185x.12025.
10
Serum complement abnormalities in the antinuclear antibody-positive relatives of children with systemic lupus erythematosus.系统性红斑狼疮患儿抗核抗体阳性亲属的血清补体异常
Arthritis Rheum. 1979 Sep;22(9):954-8. doi: 10.1002/art.1780220902.

引用本文的文献

1
Disease Expression and HLA Types in Early and Late Onset Disease of Malaysian Patients with Systemic Lupus Erythematosus.马来西亚系统性红斑狼疮患者早发型和晚发型疾病中的疾病表现及人类白细胞抗原类型
Malays J Med Sci. 2001 Jul;8(2):32-9.
2
HLA antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression.马来西亚系统性红斑狼疮患者的人类白细胞抗原(HLA)抗原:与临床及自身抗体表达的关联
Korean J Intern Med. 2001 Jun;16(2):123-31. doi: 10.3904/kjim.2001.16.2.123.